NEUROINMUNOLOGÍA
Instituto de Investigación Sanitaria Biogipuzkoa
San Sebastián, EspañaPublikationen in Zusammenarbeit mit Forschern von Instituto de Investigación Sanitaria Biogipuzkoa (3)
2022
-
Consensus statement on the use of alemtuzumab in daily clinical practice in Spain
Neurologia, Vol. 37, Núm. 8, pp. 615-630
-
Disease modifying therapy switching in relapsing multiple sclerosis: A Delphi consensus of the demyelinating expert group of the Spanish society of neurology
Multiple Sclerosis and Related Disorders, Vol. 63
2012
-
Chitinase 3-like 1 plasma levels are increased in patients with progressive forms of multiple sclerosis
Multiple Sclerosis Journal, Vol. 18, Núm. 7, pp. 983-990